Kalaris Therapeutics, Inc. (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

4.000

-0.080 (-1.96%)

At close: Sep 2, 2025, 4:00 PM

4.100

+0.100 (2.50%)

After-hours: Sep 2, 2025, 5:33 PM EDT

Kalaris Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 2, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	-	-0.39	-	-0.61
Quick Ratio	11.56	0.07	0.80	0.54
Current Ratio	11.98	0.11	0.85	0.69
Return on Assets (ROA)	-	-681.04%	-232.72%	-
Buyback Yield / Dilution	-92.38%	-9.18%	-36.56%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q